IGM Biosciences (IGMS) ROE US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| ROE, % | ? | 39.7% | 42.6% | 45.4% | 37.3% | -121.2% | -278.5% | |
| Changes by years, y/y, % | +5pp | +3pp | +3pp | -8pp | -159pp | |||
IGM Biosciences. ROE, %
IGM Biosciences. ROE, changes, pp
IGM Biosciences (IGMS) ROE US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | -92.1% | -121.2% | -146.9% | -180.1% | -278.5% | -278.5% | |
| Changes by years, y/y, % | -26pp | -158pp | -55pp | -92pp | -186pp | |||
| Changes by quarters, q/q, % | -4pp | -29pp | -26pp | -33pp | -98pp | |||